Summary: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations) Xenpozyme is the first approved medication to treat symptoms that are not related…
Highlights: ICAR-Indian Institute of Spices Research, Kozhikode, has signed an agreement with Bayer Crop Science Limited, Thane for capacity building, development of…
In order to gain access to Aerie Pharmaceuticals’ open-angle glaucoma and ocular hypertension medications, Alcon announced that it will acquire the company…
Synopsis : This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable…
Summary: Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty® unlawfully infringes patents…
Summary: The FDA has approved Axsome Therapeutics’ Auvelity for major depressive disorder (MDD) in adults, making it the first and only oral…
NEW ISO INSECTICIDE CANDIDATE PUBLISHED AUGUST 2022 – FLUPYROXYSTROBIN FROM SYNGENTA PARTICIPATIONS AG Flupyroxystrobin compound is covered in European Patent EP242081B1, which…
Summary: Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved for children as young…
Summary : Through the acquisition of Global Blood Therapeutics, Pfizer aims to enhance its presence in rare haematology and particularly sickle cell…
New ISO Candidate Published August 2022 – Flusulfinam: New herbicide candidate from Qingdao Kingagroot Chemical Compound Co., Ltd., China Suflufenam (generic name:…